Florida 2024 Regular Session

Florida House Bill H1431

Introduced
1/6/24  
Refer
1/13/24  
Introduced
1/6/24  
Refer
1/13/24  
Refer
1/13/24  
Failed
3/8/24  
Refer
1/13/24  

Caption

International Drug Reference Pricing

Impact

If passed, HB 1431 would have significant implications for how prescription drugs are priced in Florida, particularly impacting pharmacies and health insurers. The law requires pharmacies to charge no more than the established reference prices for cash-paying patients. Health insurers are also mandated to reimburse covered prescriptions at or below these reference prices, effectively lowering out-of-pocket costs for patients and potentially influencing premium rates downward. The bill is expected to enhance price transparency and lower drug costs across the state.

Summary

House Bill 1431, known as the International Drug Reference Pricing Act, aims to align the pricing of prescription drugs in Florida with that of certain international markets. The bill mandates that prescription drug manufacturers report their pricing relative to established reference price source countries, which have a GDP per capita of at least 40% of that of the U.S. The intent is to create a pricing structure that ensures patients and third-party payers do not pay more for medications than those in other countries. This efforts stems from growing concerns over the high costs of prescription drugs in the United States compared to international prices.

Contention

Despite its intended benefits, the bill has sparked a debate among stakeholders. Proponents argue that it will foster competition, drive down prices, and improve access to necessary medications for Florida residents. Opponents, however, raise concerns that pegging domestic drug prices to foreign markets may not account for the unique dynamics of the U.S. healthcare system and could result in reduced incentives for pharmaceutical innovation domestically. Additionally, there are worries about compliance burdens placed on manufacturers and insurers, which could, in turn, affect the availability of certain drugs.

Companion Bills

FL S1750

Similar To International Drug Reference Pricing

Similar Bills

AZ SB1469

Controlled substances monitoring; search warrants

AZ HB2449

Medication; authorization; mental illness

CO HB1225

Extend And Modify Prescription Drug Affordability Board

CT HB07363

An Act Prohibiting Certain Recoupment Provisions In Pharmacy Services Contracts And Concerning A Prevailing Rate Of Wages Exemption.

OR HB3082

Relating to reporting obligations for patient assistance programs for prescription drug purchases.

AZ SB1457

Psychologists; prescribing authority

AZ SB1125

Psychologists; prescribing authority

CA AB368

Food prescriptions.